Nanosonics Europe Ltd
Ground Floor Unit C1 & C2, Hercules Business Park, Bird Hall Lane, Greater Manchester, SK3 0UX
What we do:
Nanosonics is an Australian infection prevention company that has successfully developed and commercialised a unique automated disinfection technology, the trophon® device, representing the first major innovation in high level disinfection for ultrasound probes in more than 20 years. The trophon device is fast becoming the global standard of care for ultrasound probe disinfection.
How we do this:
Nanosonics constantly pursues breakthrough innovations with the potential to transform infection prevention. Our vision is to provide fail-safe infection prevention solutions that protect not only an institution’s quality of care, but more importantly the lives of those they treat. So we pioneer ground-breaking technologies to prevent life-altering infections. We set new standards that redefine best practice. And we strive to be a global leader in infection prevention innovation. OUR MISSION: We improve the safety of patients, clinics, their staff and the environment by transforming the way infection prevention practices are understood and conducted, and introducing innovative technologies that deliver improved standards of care.
Modalities/ products we cover:
Every day, 98,000 patients are protected from the risk of cross contamination because the ultrasound probe has been high-level disinfected with the trophon® device. Since 2009, the trophon devices have redefined the standard of care in ultrasound probe reprocessing providing fail-safe ultrasound probe high level disinfection (HLD) to protect patients from the risk of cross contamination. With the introduction of the trophon2 device, the world’s best just got better. The trophon2 technology has an enhanced user experience for greater workflow efficiencies and traceability across the workflow for demonstrated compliance, to deliver consistent patient protection with every automated HLD cycle.